[HTML][HTML] Treatment for emerging viruses: Convalescent plasma and COVID-19

BL Brown, J McCullough - Transfusion and Apheresis Science, 2020 - Elsevier
Use of convalescent plasma transfusions could be of great value in the current pandemic of
coronavirus disease (COVID-19), given the lack of specific preventative and therapeutic …

[HTML][HTML] Zika virus and the never-ending story of emerging pathogens and transfusion medicine

G Marano, S Pupella, S Vaglio, GM Liumbruno… - Blood …, 2016 - ncbi.nlm.nih.gov
In the last few years, the transfusion medicine community has been paying special attention
to emerging vector-borne diseases transmitted by arboviruses. Zika virus is the latest of …

A global definition of patient blood management

A Shander, JF Hardy, S Ozawa, SL Farmer… - Anesthesia & …, 2022 - journals.lww.com
While patient blood management (PBM) initiatives are increasingly adopted across the
globe as part of standard of care, there is need for a clear and widely accepted definition of …

Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016

SA Kozek-Langenecker, AB Ahmed… - European Journal of …, 2017 - journals.lww.com
The management of perioperative bleeding involves multiple assessments and strategies to
ensure appropriate patient care. Initially, it is important to identify those patients with an …

Inactivation of three emerging viruses–severe acute respiratory syndrome coronavirus, Crimean–Congo haemorrhagic fever virus and Nipah virus–in platelet …

M Eickmann, U Gravemann, W Handke… - Vox …, 2020 - Wiley Online Library
Background Emerging viruses like severe acute respiratory syndrome coronavirus (SARS‐
CoV), Crimean–Congo haemorrhagic fever virus (CCHFV) and Nipah virus (NiV) have been …

Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment

SD Keil, I Ragan, S Yonemura, L Hartson… - Vox …, 2020 - Wiley Online Library
Background and Objective Severe acute respiratory distress syndrome coronavirus‐2
(SARS‐CoV‐2), the causative agent of coronavirus disease 2019 (COVID‐19), is a member …

Inactivation of M iddle E ast respiratory syndrome coronavirus (MERS‐C o V) in plasma products using a riboflavin‐based and ultraviolet light‐based photochemical …

SD Keil, R Bowen, S Marschner - Transfusion, 2016 - Wiley Online Library
BACKGROUND Middle East respiratory syndrome coronavirus (MERS‐CoV) has been
identified as a potential threat to the safety of blood products. The Mirasol Pathogen …

Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible …

M Eickmann, U Gravemann, W Handke… - …, 2018 - Wiley Online Library
BACKGROUND Ebola virus (EBOV) and Middle East respiratory syndrome coronavirus
(MERS‐CoV) have been identified as potential threats to blood safety. This study …

Inactivation of Z ika virus in plasma with amotosalen and ultraviolet a illumination

M Aubry, V Richard, J Green, J Broult, D Musso - Transfusion, 2016 - Wiley Online Library
BACKGROUND Zika virus (ZIKV) is an arthropod‐borne virus (arbovirus) transmitted by
mosquitoes. The potential for ZIKV transmission through blood transfusion was …

[HTML][HTML] Hepatitis E virus (HEV)—The future

J Denner - Viruses, 2019 - mdpi.com
Hepatitis (HEV) is widely distributed in pigs and is transmitted with increasing numbers to
humans by contact with pigs, contaminated food and blood transfusion. The virus is mostly …